Cecilia Bottomley
Overview
Explore the profile of Cecilia Bottomley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lawson K, Hall J, Bourne T, Bottomley C
Eur J Obstet Gynecol Reprod Biol
. 2025 Feb;
307:259-264.
PMID: 39999727
Objective: To explore how women, understand, interpret and use a validated individualised early pregnancy outcome prediction score tool. Study Design: Qualitative interview study nested within a larger quantitative randomised controlled...
2.
Nijjar S, Sandhar S, Timor-Tritsch I, Agten A, Li J, Chong K, et al.
BJOG
. 2024 Nov;
132(3):278-287.
PMID: 39506920
Background: Caesarean scar ectopic pregnancy (CSEP) is associated with significant maternal and foetal morbidity. However, the optimal treatment remains unknown. Objectives: The aim of this study was to review outcomes...
3.
Nijjar S, Ngo A, de Braud L, von Stempel C, Bottomley C, Jauniaux E, et al.
Acta Obstet Gynecol Scand
. 2024 Feb;
103(6):1054-1062.
PMID: 38366724
Introduction: Cesarean scar ectopic pregnancies (CSEPs) are associated with significant maternal morbidity and termination is often recommended in the early first trimester. Management of more advanced cases is challenging due...
4.
Naftalin J, Bottomley C, Jurkovic D
Am J Obstet Gynecol
. 2022 Sep;
228(1):109.
PMID: 36108727
No abstract available.
5.
Devall A, Chu J, Beeson L, Hardy P, Cheed V, Sun Y, et al.
Health Technol Assess
. 2021 Nov;
25(68):1-114.
PMID: 34821547
Trial Design: A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne, Exelgyn, Paris, France) plus misoprostol is superior to misoprostol...
6.
Al-Memar M, Bobdiwala S, Madhra M, Saso S, De Cock B, Van Calster B, et al.
Australas J Ultrasound Med
. 2021 Nov;
21(3):138-146.
PMID: 34760514
Aim: We have assessed the potential predictive ability of the biomarkers activin B and fibronectin (FN1) alone and when added to established markers for triaging patients as being at low...
7.
Mitchell-Jones N, Lawson K, Bobdiwala S, Farren J, Tobias A, Bourne T, et al.
BMJ Open
. 2020 Oct;
10(10):e039715.
PMID: 33051235
Objectives: To assess if there is any association between hyperemesis gravidarum (HG), psychological morbidity and infant bonding and to quantify any psychosocial consequences of HG. Design: Two-point prospective case-control, multicentre...
8.
Chu J, Devall A, Beeson L, Hardy P, Cheed V, Sun Y, et al.
Lancet
. 2020 Aug;
396(10253):770-778.
PMID: 32853559
Background: The anti-progesterone drug mifepristone and the prostaglandin misoprostol can be used to treat missed miscarriage. However, it is unclear whether a combination of mifepristone and misoprostol is more effective...
9.
Coomarasamy A, Harb H, Devall A, Cheed V, Roberts T, Goranitis I, et al.
Health Technol Assess
. 2020 Jul;
24(33):1-70.
PMID: 32609084
Background: Progesterone is essential for a healthy pregnancy. Several small trials have suggested that progesterone therapy may rescue a pregnancy in women with early pregnancy bleeding, which is a symptom...
10.
Coomarasamy A, Devall A, Cheed V, Harb H, Middleton L, Gallos I, et al.
N Engl J Med
. 2019 May;
380(19):1815-1824.
PMID: 31067371
Background: Bleeding in early pregnancy is strongly associated with pregnancy loss. Progesterone is essential for the maintenance of pregnancy. Several small trials have suggested that progesterone therapy may improve pregnancy...